ArticleFrontiers in cardiovascular medicine2026
Uncoupling of energy metabolism and myocardial function in early left atrial dysfunction: a metabolomics study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left atrial (LA) dysfunction is a key preclinical phenotype of heart failure (HF), closely linked to HF progression, yet its molecular mechanisms remain unclear. Energy metabolic abnormalities may critically influence early LA dysfunction. This study aimed to explore the metabolic mechanisms underlying early LA dysfunction and develop a predictive model using metabolomics. Methods: We enrolled 315 participants, classified into early LA dysfunction and healthy control groups based on LA reservoir strain assessed via cardiovascular magnetic resonance (CMR). Targeted metabolomics was applied to detect plasma metabolites, and machine learning methods were used to construct predictive models. In addition, metabolic pathway and mediation analyses were also performed. Results: A total of 11 metabolites were significantly altered in early LA dysfunction, including elevated short-chain acylcarnitines (C4OH, C5:1) and proline, and decreased linoleic acid. C4OH and C5:1 correlated positively, while linoleic acid negatively correlated with LA reservoir strain. These metabolites distinguished early LA dysfunction from controls effectively (AUC=0.716; 95% CI: 0.616-0.817). Mediation analysis indicated that C5:1 and C5OH exacerbated LA dysfunction partly via obesity (BMI). Conclusions: Energy metabolic-mechanical function uncoupling may underlie early LA dysfunction. C4OH, C5:1, linoleic acid, and proline represent potential biomarkers and candidate metabolic pathways for future therapeutic investigation for early HF detection and intervention. Registration number: ChiCTR2200057991; Date of registration: 2022-03-25. URL: http://www.chictr.org.cn/showproj.aspx?proj=162316.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.